Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Utilizing AI-based methodologies for identifying metabolic dysfunction-related steatotic liver disease, evaluating fibrosis, and determining hepatocellular carcinoma risk: a comprehensive review

  • By

  • Anvitha Nagaraj Sharma

  • Hima Bhagavatula

  • Michael T. Mapundu

  • Emile R. Chimusa

  • July 1, 2026

Share

Original Source(s)

Harnessing AI-driven approaches for detecting metabolic dysfunction-associated steatotic liver disease, assessing fibrosis, and stratifying hepatocellular carcinoma risk: a scoping review

  • by Anvitha Nagaraj Sharma, Hima Bhagavatula, Michael T. Mapundu, Emile R. Chimusa

  • July 1, 2026

Related Content

Correction to: Prognostic factors and nomogram development for adult diffuse large B-cell lymphoma: a single-center retrospective cohort study

Editorial: Multi-omics interrogation of tumor-associated macrophages: paving the way for next-generation cancer immunotherapies

Correction: Deep learning accurately and reliably segments pelvic vascular structure in CT scans of gynecologic cancer patients